BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12359741)

  • 1. A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma.
    van Doorn R; Dijkman R; Vermeer MH; Starink TM; Willemze R; Tensen CP
    Cancer Res; 2002 Oct; 62(19):5389-92. PubMed ID: 12359741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy.
    Osella-Abate S; Zaccagna A; Savoia P; Quaglino P; Salomone B; Bernengo MG
    J Am Acad Dermatol; 2001 Jan; 44(1):40-7. PubMed ID: 11148475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline induces apoptosis in vitro in cutaneous T cell lymphoma (HuT-78) and enhances FasL mediated killing by upregulating Fas expression.
    Rishi L; Gahlot S; Kathania M; Majumdar S
    Biochem Pharmacol; 2009 Jan; 77(1):30-45. PubMed ID: 18851957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death.
    Klemke CD; Brenner D; Weiss EM; Schmidt M; Leverkus M; Gülow K; Krammer PH
    Cancer Res; 2009 May; 69(10):4175-83. PubMed ID: 19435902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma.
    Wu J; Wood GS
    Arch Dermatol; 2011 Apr; 147(4):443-9. PubMed ID: 21173302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma.
    Grønbaek K; Ralfkiaer E; Kalla J; Skovgaard GL; Guldberg P
    J Pathol; 2003 Sep; 201(1):134-40. PubMed ID: 12950026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin-homing CD8+ T lymphocytes show preferential growth in vitro and suppress CD4+ T-cell proliferation in patients with early stages of cutaneous T-cell lymphoma.
    Thestrup-Pedersen K; Parhar R; Wu K; Bertilsson PA; Meyer B; Abu-Amero S; Hainau B; Aleisa A; Alfadley A; Hamadah I; Alajlan A; Al-Hussein K; Al-Mohanna F
    Acta Derm Venereol; 2007; 87(2):118-26. PubMed ID: 17340017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Fas apoptotic pathway in cutaneous T-cell lymphomas: frequent expression of phenotypes associated with resistance to apoptosis.
    Stutz N; Johnson RD; Wood GS
    J Am Acad Dermatol; 2012 Dec; 67(6):1327.e1-10. PubMed ID: 22884443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased T-cell receptor excision circles in cutaneous T-cell lymphoma.
    Yamanaka K; Yawalkar N; Jones DA; Hurwitz D; Ferenczi K; Eapen S; Kupper TS
    Clin Cancer Res; 2005 Aug; 11(16):5748-55. PubMed ID: 16115912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation.
    Wu J; Nihal M; Siddiqui J; Vonderheid EC; Wood GS
    J Invest Dermatol; 2009 May; 129(5):1165-73. PubMed ID: 18923451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat.
    Massone C; Lozzi GP; Egberts F; Fink-Puches R; Cota C; Kerl H; Cerroni L
    J Cutan Pathol; 2006 Jun; 33(6):418-25. PubMed ID: 16776717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma.
    Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS
    Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting apoptosis defects in cutaneous T-cell lymphoma.
    Contassot E; French LE
    J Invest Dermatol; 2009 May; 129(5):1059-61. PubMed ID: 19369931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular identity of skin and blood T-cell clones in cutaneous T-cell lymphoma patients as determined from the migration pattern of the T-cell receptor-gamma gene by capillary electrophoresis.
    Gubler B; Marty-Grès S; Guillot B; Eliaou JF; Dereure O
    Electrophoresis; 2009 Mar; 30(6):999-1007. PubMed ID: 19309017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent mutations of Fas gene in thyroid lymphoma.
    Takakuwa T; Dong Z; Takayama H; Matsuzuka F; Nagata S; Aozasa K
    Cancer Res; 2001 Feb; 61(4):1382-5. PubMed ID: 11245438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue.
    Karenko L; Hahtola S; Päivinen S; Karhu R; Syrjä S; Kähkönen M; Nedoszytko B; Kytölä S; Zhou Y; Blazevic V; Pesonen M; Nevala H; Nupponen N; Sihto H; Krebs I; Poustka A; Roszkiewicz J; Saksela K; Peterson P; Visakorpi T; Ranki A
    Cancer Res; 2005 Sep; 65(18):8101-10. PubMed ID: 16166283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role.
    Ponti R; Bergallo M; Costa C; Quaglino P; Fierro MT; Comessatti A; Stroppiana E; Sidoti F; Merlino C; Novelli M; Alotto D; Cavallo R; Bernengo MG
    Br J Dermatol; 2008 Nov; 159(5):1131-7. PubMed ID: 18782321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of anti-fas ribozyme on apoptosis of mouse T cells.
    Zhang M; Chen ZC; Tian L; Liu F; Liu LB; You Y; Zou P
    Ai Zheng; 2005 May; 24(5):520-4. PubMed ID: 15890090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.